Product NDC: | 63323-407 |
Proprietary Name: | Caffeine Citrate |
Non Proprietary Name: | CAFFEINE CITRATE |
Active Ingredient(s): | 20 mg/mL & nbsp; CAFFEINE CITRATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-407 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077997 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091119 |
Package NDC: | 63323-407-03 |
Package Description: | 1 VIAL in 1 BOX (63323-407-03) > 3 mL in 1 VIAL |
NDC Code | 63323-407-03 |
Proprietary Name | Caffeine Citrate |
Package Description | 1 VIAL in 1 BOX (63323-407-03) > 3 mL in 1 VIAL |
Product NDC | 63323-407 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CAFFEINE CITRATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091119 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | CAFFEINE CITRATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |